Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in human glioblastoma preclinical models

Autor: Djedid, R., Mathieu, V., LeMercier, M., Lefranc, F.

Publikováno v: In Surgical Neurology 2009 72(5):525-525

Le bévacizumab (Avastin) augmente l’efficacité antitumorale du témozolomide dans un modèle préclinique de glioblastome

Autor: Djedid, R., Mathieu, V., LeMercier, M., Kiss, R., Lefranc, F.

Publikováno v: In Neurochirurgie 2009 55(4):496-496

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Natural history of ventriculostomy-related infection under appropriate treatment and risk factors of poor outcome: a retrospective study.

Autor: Mounier R; Departments of1Anesthesia and Surgical Intensive Care., Birnbaum R; Departments of1Anesthesia and Surgical Intensive Care., Cook F; Departments of1Anesthesia and Surgical Intensive Care., Jost PH; Departments of1Anesthesia and Surgical Intensive Care., Martin M; Departments of1Anesthesia and Surgical Intensive Care., Aït-Mamar B; Departments of1Anesthesia and Surgical Intensive Care., Nebbad B; 2Microbiology, and., Couffin S; Departments of1Anesthesia and Surgical Intensive Care., Tomberli F; Departments of1Anesthesia and Surgical Intensive Care., Djedid R; 3Neurosurgery, Henri Mondor University Hospital of Paris, Paris XII School of Medicine, Créteil, France., Dhonneur G; Departments of1Anesthesia and Surgical Intensive Care., Lobo D; Departments of1Anesthesia and Surgical Intensive Care.

Publikováno v: Journal of neurosurgery [J Neurosurg] 2018 Nov 16; Vol. 131 (4), pp. 1052-1061. Date of Electronic Publication: 2018 Nov 16 (Print Publication: 2019).